Phosphines with N-heterocyclic boranyl substituents

DOI: 10.1039/c3dt52441h

Source and publish data:

Dalton Transactions p. 680 - 689 (2014)

Update date:2022-07-29

Topics:

Authors:

Kaaz Kaaz

Bender Bender

Foerster

Frey Frey

Nieger Nieger

Gudat Gudat

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1039/c3dt52441h

A lithio-diazaborole reacted with diamino-chlorophosphines via metathesis to yield previously unavailable phosphinoboranes bearing amino substituents at both the phosphorus and boron atoms, and with Ph₂PCl and Mes*PCl₂via chloride tr

Full text of DOI:10.1039/c3dt52441h

Products guided by the article

Product name:1,3-bis(2,6-di-isopropylphenyl)-2-diphenylphosphino-1,3,2-diazaborole

Cas No:1514824-89-5

R&D Labs maybe for 1514824-89-5

XI'AN CHUKANG BIOTECHNOLOGY CO.,LTD

Contact:29-63685658 63685359

Address:Room 3-1202,Building 1,Oriental oasis,East of Xianning Road,Xi'an,Shaanxi 710043 P.R.China
Hangzhou LINGEBA Technology Co., Ltd.

Contact:+0086-571-87389059

Address:Office 1-913,NewYouth Plaza, GongShu Area, HangZhou,ZheJiang,P.R.China
SJZ Chenghui Chemical Co., Ltd.

Contact:86-311-87713916

Address:no.368 youyi north avenue
Winchem Industrial Co. Ltd.(expird)

Contact:86-574-83851061 86-574-87083208

Address:Room 905, No.3 Building,East Business Center, 456 Xingning Road, Ningbo City,China
HANGZHOU TOYOND BIOTECH CO., LTD

Contact:+86-571-86965177

Address:No. 189, Fengqi East Road, Hangzhou, China

Relevant to this article

Efficient, traceless semi-synthesis of α-synuclein labeled with a fluoro phore/thioamide FRET pair

Doi:10.1055/s-0033-1339853
(2013)
Thioamide-Directed Cobalt(III)-Catalyzed Selective Amidation of C(sp³)?H Bonds

Doi:10.1002/anie.201709273
(2017)
Urethane protected derivatives of 1-guanylpyrazole for the mild and efficient preparation of guanidines

Doi:10.1016/S0040-4039(00)79163-5
(1993)
Doi:10.1016/S0040-4020(01)97150-9
(1974)
Steric tuning in chiral ligand mediated enantioselective alkylation of imines

Doi:10.1016/S0957-4166(00)80366-3
(1993)
Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC)

Doi:10.1016/j.bmcl.2013.11.034
(2014)

Article Doi